Taysha Gene Therapies Inc (TSHA) — Financial Flexibility Index
Taysha Gene Therapies Inc (TSHA) has a Financial Flexibility Index of -0.49x as of June 2026. Free cash flow of $-40.42 Million (operating CF $-40.42 Million minus capex $1.00K) represents 0% of total liabilities ($83.17 Million). Check cash flow reinvestment rate of Taysha Gene Therapies Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Taysha Gene Therapies Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Taysha Gene Therapies Inc across 7 annual periods. For the full cash flow conversion analysis, see Taysha Gene Therapies Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Taysha Gene Therapies Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Taysha Gene Therapies Inc. Explore debt repayment capacity of Taysha Gene Therapies Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-92.35 Million | $-93.09 Million | $96.38 Million | ▼ -5.3% |
| 2024 | -0.91x | $-80.85 Million | $-81.22 Million | $88.84 Million | ▼ -35.6% |
| 2023 | -0.67x | $-65.65 Million | $-73.02 Million | $97.79 Million | ▼ -32.4% |
| 2022 | -0.51x | $-63.52 Million | $-88.39 Million | $125.33 Million | ▲ +37.1% |
| 2021 | -0.81x | $-95.49 Million | $-117.04 Million | $118.57 Million | ▲ +71.8% |
| 2020 | -2.86x | $-21.65 Million | $-30.73 Million | $7.58 Million | ▼ -297.4% |
| 2019 | 1.45x | $217.00K | $135.00K | $150.00K | — |